TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
出版年份 2020 全文链接
标题
TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
作者
关键词
-
出版物
Cell Death & Disease
Volume 11, Issue 2, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-05
DOI
10.1038/s41419-020-2272-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cryo-EM structure of the human ferritin–transferrin receptor 1 complex
- (2019) Linda Celeste Montemiglio et al. Nature Communications
- Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
- (2019) Yuxuan Miao et al. CELL
- Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
- (2018) Kelong Fan et al. ACS Nano
- A Self-Targeting, Dual ROS/pH-Responsive Apoferritin Nanocage for Spatiotemporally Controlled Drug Delivery to Breast Cancer
- (2018) Bin Du et al. BIOMACROMOLECULES
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rethinking cancer nanotheranostics
- (2017) Hongmin Chen et al. Nature Reviews Materials
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer
- (2015) Chuncheng Hao et al. CANCER LETTERS
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit
- (2013) Wei Zhao et al. CANCER CELL
- Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
- (2013) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
- (2012) Kelong Fan et al. Nature Nanotechnology
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Absence of CD71 Transferrin Receptor Characterizes Human Gastric Adenosquamous Carcinoma Stem Cells
- (2011) Masahisa Ohkuma et al. ANNALS OF SURGICAL ONCOLOGY
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- CXCR3 ligands: redundant, collaborative and antagonistic functions
- (2011) Joanna R Groom et al. IMMUNOLOGY AND CELL BIOLOGY
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Magnetic separation and characterization of keratinocyte stem cells from human gingiva
- (2010) B. Calenic et al. JOURNAL OF PERIODONTAL RESEARCH
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
- (2010) Li Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
- (2009) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery
- (2009) Jau Yi Li et al. DEVELOPMENTAL CELL
- Nanoparticle-based targeted drug delivery
- (2009) Rajesh Singh et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search